While most individuals may not notice any personal benefit resulting from the well-celebrated completion of the sequencing of the human genome in 2003, researchers and physicians say that the information gleaned has changed care for many patients with various conditions and will increasingly do so in the years ahead. And one area the human genome information is expected to revolutionize is pharmacogenomics, the science of how genes affect the way individuals respond to drugs.
Hampton T. Researchers Draft Guidelines for Clinical Use of Pharmacogenomics. JAMA. 2006;296(12):1453–1454. doi:10.1001/jama.296.12.1453